Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial.
paper
Cited
Public
- Authors
- Guertin, Kristin A; Gu, Fangyi; Wacholder, Sholom; Freedman, Neal D; Panagiotou, Orestis A; Reyes-Guzman, Carolyn; Caporaso, Neil E
- Year
- 2015
- Journal
- PloS one
- PMID
- 25985429
- DOI
- 10.1371/journal.pone.0125973
- PMCID
- PMC4436174
BACKGROUND: Time to first cigarette (TTFC) after waking is an indicator of nicotine dependence. The association between TTFC and chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States, has not yet been reported. METHODS: We investigated the cross-sectional association between TTFC and prevalent COPD among 6,108 current smokers in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. COPD was defined as a self-reported diagnosis of emphysema, chronic bronchitis, or both. Current smokers in PLCO reported TTFC, the amount of time they typically waited before smoking their first cigarette of the day after waking, in four categories: ≤ 5, 6-30, 31-60, or > 60 minutes. We used logistic regression models to investigate the association between TTFC and prevalent COPD with adjustments for age, gender, race, education, and smoking (cigarettes/day, years smoked during lifetime, pack-years, age at smoking initiation), and prior lung cancer diagnosis. RESULTS: COPD was reported by 19% of these 6,108 smokers. Individuals with the shortest TTFC had the greatest risk of COPD; compared to those with the longest TTFC (> 60 minutes) the adjusted odds ratios (OR) and 95% confidence intervals (CI) for COPD were 1.48 (95% CI, 1.15-1.91), 1.64 (95% CI, 1.29-2.08), 2.18 (95% CI, 1.65-2.87) for those with TTFC 31-60 minutes, 6-30 minutes, and ≤ 5 minutes, respectively (P-trend < 0.0001). The association between TTFC and emphysema was similar to that for bronchitis, albeit the ORs were slightly stronger for chronic bronchitis; comparing TTFC ≤5 minutes to > 60 minutes, the adjusted OR (95% CI) was 2.29 (1.69-3.12) for emphysema and 2.99 (1.95-4.59) for chronic bronchitis. CONCLUSIONS: Current smokers with shorter TTFC have increased risk of COPD compared to those with longer TTFC, even after comprehensive adjustment for established smoking covariates. Future epidemiologic studies, including prospective designs, should incorporate TTFC to better assess disease risk and evaluate the potential utility of TTFC as a COPD screening tool for smokers in the clinical setting.
Time to first cigarette (TTFC) upon waking and risk of chronic obstructive pulmonary disease (COPD) among current smokers.Odds Ratios for each category of TTFC (≤5, 6–30, and 31–60 minutes, compared to the reference group of smokers with TTFC >60 minutes) were calculated by logistic regression, adjusted for age, gender (except in gender-stratified analyses), race, education, cigarettes/day, years smoked during lifetime, pack-years, age at smoking initiation, and lung cancer diagnosis prior to follow-up questionnaire. (A) OR for COPD, emphysema, and chronic bronchitis. (B) OR for COPD by age at smoking initiation. (C) OR for COPD by typical number of cigarettes smoked per day. (D) OR for COPD by pack-years. (E) OR for COPD by total smoking duration in years. Categories of smoking covariates were collapsed for visual representation of results; refer to Table 2 for further details.
1–20 of 33
Next →
| Name | Type |
|---|---|
| addiction | phenotype |
| African American | cohort |
| age at smoking initiation | phenotype |
| asymptomatic smokers local | cohort |
| Canadian cohort local | cohort |
| chronic bronchitis | phenotype |
| chronic obstructive pulmonary disease | phenotype |
| chronic obstructive pulmonary disease (COPD) | phenotype |
| Cigarette-associated Carcinogens local | drug |
| cigarettes | phenotype |
| colorectal cancer | phenotype |
| consumption patterns | phenotype |
| COPD | phenotype |
| COPD severity local | phenotype |
| cotinine | drug |
| CT-defined emphysema local | phenotype |
| Current smokers (PLCO) local | cohort |
| current smoking | phenotype |
| duration of smoking | phenotype |
| Emergency-room admission local | phenotype |
| emphysema | phenotype |
| Fagerström Test for Nicotine Dependence | phenotype |
| family history of COPD local | phenotype |
| former smokers | phenotype |
| FTND score | phenotype |
| high nicotine dependence | phenotype |
| high smoking intensity local | phenotype |
| Individuals who quit smoking after COPD diagnosis local | cohort |
| late smoking initiation local | phenotype |
| lung cancer | phenotype |
| Lung density local | phenotype |
| lung disease local | phenotype |
| Lung disease local | phenotype |
| Lung Disease local | phenotype |
| men | cohort |
| negative symptoms | phenotype |
| nicotine | drug |
| nicotine addiction | phenotype |
| nicotine dependence | phenotype |
| NNAL local | drug |
| non-cases local | cohort |
| non-Hispanic whites | cohort |
| ovarian cancer | phenotype |
| pack-years | phenotype |
| participants with complete follow-up questionnaire data local | cohort |
| PLCO | cohort |
| PLCO Cancer Screening Trial local | cohort |
| PLCO cohort local | cohort |
| PLCO trial local | cohort |
| prostate cancer | phenotype |
| Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) local | cohort |
| race/ethnicity | phenotype |
| sex | phenotype |
| smoking | phenotype |
| smoking behavior | phenotype |
| Smoking cessation local | drug |
| Smoking-related conditions local | phenotype |
| Smoking-Related Disease Risk local | phenotype |
| supraglottic cancer local | phenotype |
| time to first cigarette | phenotype |
| Time to First Cigarette (TTFC) local | phenotype |
| TTFC 31–60 minutes local | phenotype |
| TTFC ≤5 minutes local | phenotype |
| TTFC >60 minutes local | phenotype |
| TTFC 6–30 minutes local | phenotype |
| United States | cohort |
| US cohort local | cohort |
| very early morning smoking local | phenotype |
| women | cohort |
| Years Smoked local | phenotype |
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AnthonisenNR, ConnettJE, MurrayRP. Smoking and Lung Function of Lung Health Study Participants after 11 Years. American Journal of Respiratory and Critical Care Medicine. 2002 9 1;166(5):675–9. 10.1164/rccm.2112096 12204864 | — | — | — |
| BakerTB, PiperME, McCarthyDE, BoltDM, SmithSS, KimS-Y, et al Time to First Cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research. 2007 12 1, 2007;9(Suppl 4):S555–S70. 10.1080/14622200701673480 18067032PMC2933747 | — | — | — |
| BerlinI, SingletonEG. Nicotine dependence and urge to smoke predict negative health symptoms in smokers. Preventive Medicine. 2008;47(4):447–51. 10.1016/j.ypmed.2008.06.008 18602945 | — | — | — |
| BernsteinSL, BoudreauxED, CabralL, CydulkaRK, SchwegmanD, LarkinGL, et al Nicotine dependence, motivation to quit, and diagnosis among adult emergency department patients who smoke: A national survey. Nicotine & Tobacco Research. 2008 8 1, 2008;10(8):1277–82. 10.1080/14622200802239272 18686174 | — | — | — |
| BranstetterSA, MuscatJE. Time to First Cigarette and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) levels in adult smokers: National Health and Nutrition Examination Survey (NHANES) 2007–2010. Cancer Epidemiology Biomarkers & Prevention. 2013 4 1, 2013;22(4):615–22. 10.1158/1055-9965.epi-12-0842 23542804 | — | — | — |
| Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults—United States, 2005–2012. 2014.PMC458464824430098 | — | — | — |
| Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR: Morbidity and Mortality Weekly Report. 2008;57:1226–8. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm. 19008791 | — | — | — |
| ForeyBA, ThorntonAJ, LeePN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulmonary Medicine. 2011;11:36 Pubmed Central PMCID: 3128042. Epub 2011/06/16. 10.1186/1471-2466-11-36 21672193PMC3128042 | — | — | — |
| GohaganJK, ProrokPC, HayesRB, KramerBS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status. Control Clin Trials. 2000 12;21(6 Suppl):251S–72S. .1118968310.1016/s0197-2456(00)00097-0 | — | — | — |
| GuF, WacholderS, KovalchikS, PanagiotouOA, Reyes-GuzmanC, FreedmanND, et al Time to smoke first morning cigarette and lung cancer in a case—control study. Journal of the National Cancer Institute. 2014;106(6). 10.1093/jnci/dju118 PMC407290124948709 | — | — | — |
| HatsukamiDK, LeCT, ZhangY, JosephAM, MooneyME, CarmellaSG, et al Toxicant exposure in cigarette reducers versus light smokers. Cancer Epidemiol Biomarkers Prev. 2006 12;15(12):2355–8. 10.1158/1055-9965.EPI-06-0240 17164356PMC6512339 | — | — | — |
| HeathertonTF, KozlowskiLT, FreckerRC, FagerstromKO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction. 1991 9;86(9):1119–27. .193288310.1111/j.1360-0443.1991.tb01879.x | — | — | — |
| HechtSS, CarmellaSG, MurphySE, AkerkarS, BrunnemannKD, HoffmannD. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 11 18;329(21):1543–6. 10.1056/NEJM199311183292105 8413477 | — | — | — |
| HerningRI, JonesRT, BenowitzNL, MinesAH. How a cigarette is smoked determines blood nicotine levels. Clinical pharmacology and therapeutics. 1983 1;33(1):84–90. 10.1038/clpt.1983.12 6848303 | — | — | — |
| Jiménez RuizCA, Ramos PinedoA, Cicero GuerreroA, Mayayo UlibarriM, Cristobal FernándezM, Lopez GonzalezG. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine & Tobacco Research. 2012 9 1, 2012;14(9):1035–9. 10.1093/ntr/nts001 22345320 | — | — | — |
| Jiménez-RuizCA, MasaF, MiravitllesM, GabrielR, ViejoJL, VillasanteC, et al Smoking characteristics: Differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001;119(5):1365–70. 10.1378/chest.119.5.1365 11348940 | — | — | — |
| Jiménez-RuizCA, MiravitllesM, SobradilloV, GabrielR, ViejoJL, MasaJF, et al Can cumulative tobacco consumption, FTND score, and carbon monoxide concentration in expired air be predictors of chronic obstructive pulmonary disease? Nicotine & Tobacco Research. 2004 8 1, 2004;6(4):649–53. 10.1080/14622200410001727948 15370161 | — | — | — |
| KannerRE, ConnettJE, WilliamsDE, BuistAS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med. 1999 4;106(4):410–6. 10.1016/S0002-9343(99)00056-X 10225243 | — | — | — |
| KimDK, HershCP, WashkoGR, HokansonJE, LynchDA, NewellJD, et al Epidemiology, radiology, and genetics of nicotine dependence in COPD. Respiratory Research. 2011;12:9 Pubmed Central PMCID: 3033825. 10.1186/1465-9921-12-9 21232152PMC3033825 | — | — | — |
| KubikA, ZatloukalP, TomasekL, DolezalJ, SyllabovaL, KaraJ, et al A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma. 2008;55(3):192–9. .18348651 | — | — | — |
| KunzeU, SchölerE, SchoberbergerR, DittrichC, AignerK, BölcskeiP, et al Lung Cancer Risk Measured by the Fagerström Test for Nicotine Dependence? Nicotine & Tobacco Research. 2007 5 1, 2007;9(5):625–6. 10.1080/14622200601096998 17454720 | — | — | — |
| MurgiaN, BrismanJ, ClaessonA, MuziG, OlinA-C, TorenK. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulmonary Medicine. 2014;14(1):49 10.1186/1471-2466-14-49 24650114PMC3994476 | — | — | — |
| MuscatJ, LiuH-P, LivelsbergerC, RichieJJr., StellmanS. The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes & Control. 2012 2012/03/01;23(3):497–503. 10.1007/s10552-012-9909-x 22367700PMC3695606 | — | — | — |
| MuscatJE, AhnK, RichieJP, StellmanSD. Nicotine dependence phenotype and lung cancer risk. Cancer. 2011;117(23):5370–6. 10.1002/cncr.26236 21826644PMC3213292 | — | — | — |
| MuscatJE, StellmanSD, CaraballoRS, RichieJP. Time to First Cigarette after waking predicts cotinine levels. Cancer Epidemiology Biomarkers & Prevention. 2009 12 1, 2009;18(12):3415–20. 10.1158/1055-9965.epi-09-0737 PMC295242419959690 | — | — | — |
| National Heart Lung and Blood Institute. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. 2012. Available from: Available: http://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf. | — | — | — |
| ProrokP, AndrioleG, BresalierR. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6 Suppl):273S–309S. 1118968410.1016/s0197-2456(00)00098-2 | — | — | — |
| QaseemA, WiltT, WeinbergerS, HananiaN, CrinerG, van der MolenT, et al Diagnosis and management of stable Chronic Obstructive Pulmonary Disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–91. 10.7326/0003-4819-155-3-201108020-00008 21810710 | — | — | — |
| RostronBL, ChangCM, PechacekTF. Estimation of cigarette smoking—attributable morbidity in the United States. JAMA Internal Medicine. 2014 10.1001/jamainternmed.2014.5219 25317719 | — | — | — |
| SchnollRA, GorenA, AnnunziataK, SuayaJA. The prevalence, predictors and associated health outcomes of high nicotine dependence using three measures among US smokers. Addiction. 2013;108(11):1989–2000. 10.1111/add.12285 23795712 | — | — | — |
| ShahabL, JarvisMJ, BrittonJ, WestR. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7. Pubmed Central PMCID: 2117062. 10.1136/thx.2006.064410 17040932PMC2117062 | — | — | — |
| van der MeerRM, WagenaEJ, OsteloRW, JacobsJE, van SchayckCP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001 (1). 10.1002/14651858 PMC645788012804448 | — | — | — |
| VozorisNT, StanbrookMB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respiratory Medicine. 2011;105(3):477–84. 10.1016/j.rmed.2010.08.011 20850288 | — | — | — |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Deep multi-omics profiling reveals three molecular subtypes of chronic obstructive pulmonary disease in a unique biomass-exposed Chinese population. | Wu W et al. | — | 2026 | → |
| Time from waking to first cigarette, genetic susceptibility, and the risk of COPD: A Prospective cohort study from UK Biobank. | Qiqi L et al. | — | 2026 | → |
| Morning cannabis use in young adults: Associations with overall levels of use, negative consequences, and cannabis use disorder symptoms across 2.5 years. | Calhoun BH et al. | — | 2024 | → |
| Smoking-Related Increases in Alcohol Outcomes and Preliminary Evidence for the Protective Effect of a Functional Nicotine Receptor Gene (CHRNA5) Variant on Alcohol Consumption in Individuals Without Alcohol Use Disorder. | Venkatesh SK et al. | — | 2024 | → |
| Alcohol and Nicotine Dependence and Time to Death in a General Adult Population: A Mortality Cohort Study. | John U et al. | — | 2023 | → |
| Association of nicotine dependence and gut microbiota: a bidirectional two-sample Mendelian randomization study. | Chen Y et al. | — | 2023 | → |
| Cigarette dependence is more prevalent and increasing among US adolescents and adults who use cannabis, 2002-2019. | Weinberger AH et al. | — | 2023 | → |
| "Wake-and-bake" cannabis use: Predictors and cannabis-related outcomes of use shortly after waking. | Calhoun BH et al. | — | 2023 | → |
| Association of the Time to First Cigarette and the Prevalence of Chronic Respiratory Diseases in Chinese Elderly Population. | Wang C et al. | — | 2022 | → |
| Household Smoking Restrictions, Time to First Cigarette and Tobacco Dependence. | Branstetter SA et al. | — | 2021 | → |
| Origins of human disease: the chrono-epigenetic perspective. | Oh ES et al. | — | 2021 | → |
| Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits. | Quach BC et al. | — | 2020 | → |
| Expanding the Genetic Architecture of Nicotine Dependence and its Shared Genetics with Multiple Traits: Findings from the Nicotine Dependence GenOmics (iNDiGO) Consortium | Quach BC et al. | — | 2020 | — |
| Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. | Chen J et al. | — | 2020 | → |
| 'Time to first tobacco cigarette soon after waking' occurs more often among underage newly incident smokers in the United States, 2004-2017. | Xue W et al. | — | 2020 | → |
| Nicotine dependence as an independent risk factor for atherosclerosis in the National Lung Screening Trial. | Zhu J et al. | — | 2019 | → |
| Time to First Cigarette and Self-Reported Health Among US Adult Smokers. | Sung B | — | 2019 | → |
| Association of Time to First Morning Cigarette and Chronic Obstructive Pulmonary Disease Measured by Spirometry in Current Smokers. | Kim G et al. | — | 2018 | → |
| CYP2A6 metabolism in the development of smoking behaviors in young adults. | Olfson E et al. | — | 2018 | → |
| Earlier smoking after waking and the risk of asthma: a cross-sectional study using NHANES data. | Selya AS et al. | — | 2018 | → |
| Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. | Hancock DB et al. | — | 2018 | → |
| The outcome and the influencing factors of the age of onset in post-mortem of chronic bronchitis patients: a retrospective study. | Zhu L et al. | — | 2018 | → |
| Time to First Cigarette, a Proxy of Nicotine Dependence, Increases the Risk of Pulmonary Impairment, Independently of Current and Lifetime Smoking Behavior. | Selya AS et al. | — | 2016 | → |
| Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence. | Hancock DB et al. | — | 2015 | → |